Flu News and Research

RSS

SARS-CoV-2 infection can elevate the risk of serious complications during pregnancy

Pregnant individuals infected with SARS-CoV-2, the virus that causes COVID-19, are about 40% more likely to develop serious complications or die during pregnancy than those who aren’t infected with the virus, according to a nationwide study led by a University of Utah Health obstetrician.

7 Feb 2022

Understanding public responses to UK's COVID test, trace and isolate measures

Researchers investigate the public behaviors in response to the United Kingdom test, trace, and isolate (TTI) policy in July 2021.

3 Feb 2022

Study reveals peripheral blood biomarkers able to predict COVID-19 clinical outcomes in ICU admission

A new study involved the development of an immunological biomarker screen that upon ICU admission can predict the length of ICU stay or death.

3 Feb 2022

UK's world-leading human challenge study provides new insights into mild SARS-CoV-2 infections

Findings from the UK's world-leading human challenge study provide new insights into mild infections with SARS-CoV-2 in healthy young adults.

2 Feb 2022

New app and lab kit transform a smartphone into COVID-19 / flu detection system

In a potential game changer for COVID-19 pandemic control efforts, a new cell phone app and lab kit have transformed a smartphone into a COVID-19 / flu detection system.

29 Jan 2022

Spike-mediated CFTR inhibition accounts for airway inflammation in COVID-19

A new study looks at the molecular level inhibition of the protective CFTR gene by the SARS-CoV-2 spike protein.

25 Jan 2022

Immunogenicity to BNT162b2 booster in adults who had previously received inactivated COVID-19 vaccination

A new preprint available on medRxiv* demonstrates the marked improvement in the immune response when the mRNA vaccine BNT162b2, from Pfizer/BioNTech, is used for the third dose after a primary two-dose series of an inactivated whole virus vaccine.

25 Jan 2022

Neurological complications of the SARS-CoV-2 vaccine

In a study published in the latest issue of the journal Neurological Sciences, a team of researchers described a three-patient case series presenting with neurological manifestations after the coronavirus disease 2019 (COVID-19) vaccination, followed by a literature review, to propose hypotheses on how neurological symptoms might develop after vaccination.

24 Jan 2022

New, low-cost COVID-19 test could make high-performance testing more accessible

Researchers at the University of Washington have developed a new test for COVID-19 that combines the speed of over-the-counter antigen tests with the accuracy of PCR tests that are processed in medical labs and hospitals.

24 Jan 2022

Short- and long-term systemic responses in the golden hamster following SARS-CoV-2 or influenza A virus infection

A group of researchers used the golden hamster as a model system to better understand the long-term impacts of SARS-CoV-2 infection.

24 Jan 2022

Incidence of SARS-CoV-2 infections in orchestra and choir musicians

A new study aimed to study the incidence of SARS-CoV-2 infections in orchestra and choir musicians compared to controls.

24 Jan 2022

Antimicrobial resistance causes more deaths than HIV and malaria

Antibiotic-resistant bacterial infections resulted in more than 1.2 million deaths worldwide in 2019, exceeding the number caused by HIV/AIDS and malaria, says a study spanning 204 countries and territories.

22 Jan 2022

Echinacea as a potential force against coronavirus infections

A new review identified clinical studies evaluating coronavirus infections in the context of Echinacea administration and assessed preventive and therapy advantages against COVID-19.

21 Jan 2022

Exploring the likelihood of SARS-CoV-2 becoming an endemic disease

Several deadly pandemics have emerged in human history that have either disappeared or turned into epidemics. Researchers explored the likelihood that SARS-CoV-2 would also eventually become an endemic disease.

21 Jan 2022

New COVID-19 vaccine promises vaccine equity because it has no patents

Corbevax, a new vaccine against COVID-19, may have better success as a candidate for vaccine equity because it carries no patents, relies on long-established recombinant technology for manufacture and has the support of the US and Indian governments, its makers and health experts say.

21 Jan 2022

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

In a new study, researchers discuss the role of calcium signaling pathways as targets of inhibition in potential new antiviral therapeutic pathways for SARS-CoV-2.

20 Jan 2022

Scientists support the rollout of portable CO2 monitors to UK schools

UK schools have received more than 300,000 CO2 monitors as part of a government initiative to reduce COVID-19 spread in classrooms.

17 Jan 2022

Study analyzes the impact of global trust in government due to the COVID-19 pandemic

In a week when the UK Prime Minister Boris Johnson has admitted to breaking Covid-19 lockdown rules, a new study has found that impartial, transparent and truthful government communications are fundamental for achieving and maintaining government trust during public health emergencies.

17 Jan 2022

As omicron surges, effort to vaccinate young children stalls

Two months after Pfizer's covid vaccine was authorized for children ages 5 to 11, just 27% have received at least one shot, according to Jan. 12 data from the Centers for Disease Control and Prevention. Only 18%, or 5 million kids, have both doses.

15 Jan 2022

Flu vaccines can be lifesaving for children, study shows

A new CDC study published in the journal Clinical Infectious Diseases (CID) shows that flu vaccination protected children against serious flu illness even when they were infected with a flu virus that was antigenically different from the vaccine virus.

13 Jan 2022